Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2023-09-18 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
第五届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the fourth meeting of the fifth board of directors of Shanghai Chenguang Medical Technology Co., Ltd. It details the meeting date, attendance, and voting results on various proposals related to company governance, internal rules, and management appointments. The document references other announcements and disclosures on the Beijing Stock Exchange information platform but does not itself contain financial statements or detailed financial data. It is primarily a board meeting resolution announcement, focusing on governance and management matters rather than financial results or audit information. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is about 4758 characters, which is sufficient for a detailed announcement but not a full report like an annual or interim report.
2023-09-18 Chinese
海通证券股份有限公司关于上海辰光医疗科技股份有限公司关联担保事项的核查意见
Regulatory Filings
2023-09-18 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is titled as an "Information Disclosure Management System" of Shanghai Chenguang Medical Technology Co., Ltd. It details the company's policies, procedures, and responsibilities regarding information disclosure, including regulatory compliance, timing, content, and management of disclosures. It references regulatory bodies such as the China Securities Regulatory Commission and the Beijing Stock Exchange, and covers topics like periodic reports, temporary reports, insider information, and disclosure obligations. The document is a comprehensive governance and procedural manual rather than a financial report, earnings release, or announcement. It does not contain financial statements or results but rather outlines the internal rules and governance practices related to information disclosure. Therefore, the document best fits the category of Governance Information (CGR).
2023-09-18 Chinese
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled "独立董事工作制度" which translates to "Independent Director Work System". It details the rules, qualifications, duties, and protections for independent directors of the company Shanghai Chunguang Medical Technology Co., Ltd. It references relevant laws, regulations, and stock exchange rules. The content is a governance framework document rather than a report of financial results, management changes, or meeting materials. It is not an announcement of a report but a detailed governance policy document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-09-18 Chinese
承诺管理制度
Governance Information Classification · 95% confidence The document is titled '承诺管理制度' (Commitment Management System) and details the company's internal rules and procedures regarding commitments made by controlling shareholders, directors, supervisors, senior management, and related parties. It references relevant laws and regulations, outlines the responsibilities and disclosure requirements related to commitments, and specifies the governance and approval processes for changes or exemptions to commitments. The document is issued by the company's board and is dated September 19, 2023. It does not contain financial statements, audit results, voting results, or any direct financial performance data. Instead, it focuses on governance policies and internal management systems. Therefore, this document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-09-18 Chinese
关联交易公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding a related party transaction involving a credit facility and mortgage guarantee provided by the controlling shareholder and actual controller of the company. It includes details about the transaction, board approval, and independent opinions, but does not contain financial statements or results. The document is relatively short (1401 characters) and is an announcement of a specific financing-related transaction. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2023-09-18 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.